Abstract

Neonatal screening is a critical public health initiative that facilitates the early detection of serious congenital conditions in newborns, enabling timely interventions that significantly improve health outcomes. Conducted shortly after birth, this proactive approach aims to identify conditions such as metabolic disorders, endocrine disorders, and genetic disorders that may not present symptoms at birth but can lead to severe health complications if left untreated. The effectiveness of neonatal screening hinges on various factors, including the types of conditions screened, the processes involved, and the infrastructure supporting these programs. Despite its significant benefits, challenges such as access disparities, public awareness, and resource allocation persist. This article highlights the essential role of neonatal screening in promoting optimal infant health and underscores the need for continued investment in screening programs to ensure equitable access and improve long-term outcomes for all newborns.